Introduction to haematological malignancies Flashcards
Epidemiology of haematological malignancies
10% of human cancers
all age groups
adult males > females
Hodgkins lymphoma age peak
18-35
AML+ non Hodgkin age
increasing age - 65/70 start to peak
Pathogenesis of haematological malignancies
multi step process
acquired genetic alterations to a long lived cell
survival/proliferative advantage
malignant clone dominates tissue
ALL cells
lymphoid progenitor cells
AML cells
myeloid progenitor cells
myeloproliferative disorders cells
neutrophils basophils eosinophils monocytes platelets RBC
CLL cells
B lymphocytes
lymphoma cells
mature T and B cells (germinal centre)
myeloma cells
plasma cells
leukaemia vs lymphoma
area of distribution
leukaemia = bone marrow and blood
lymphoma = Lymph glands
Acute leukaemia
cells do not differentiate
rapidly fatal if untreated
bone marrow failure
potentially curable
chronic leukaemia
leukaemic cells retain ability to differentiate
no bone marrow failure
survival for few years
potentially curable
Modern therapy for chronic leukaemia
tyrosine kinase inhibitors
Clinical features of acute leukaemia
anaemia
thrombocytopenic bleeding
infection - bacterial and fungal